PGI14 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE: SHOULD EMERGING SAFETY CONCERNS AFFECT THERAPEUTIC DECISION-MAKING?

2008 ◽  
Vol 11 (3) ◽  
pp. A87-A88
Author(s):  
PB Ryan ◽  
AK Biddle
Keyword(s):  
Decision Making ◽  
Cost Effectiveness ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Reflux Disease ◽  
Therapeutic Decision ◽  
Safety Concerns ◽  
Therapeutic Decision Making

scholarly journals Vonoprazan versus proton pump inhibitors for the management of gastroesophageal reflux disease

Medicine ◽  
2018 ◽  
Vol 97 (39) ◽  
pp. e12574 ◽  
Author(s):  
Hyun Kang ◽  
Beom Jin Kim ◽  
Geunjoo Choi ◽  
Jae Gyu Kim
Keyword(s):  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Reflux Disease

Mo1083 Risk Factors for Relapse of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients Previously Succeeded With Proton Pump Inhibitors Treatment

2012 ◽  
Vol 142 (5) ◽  
pp. S-590-S-591
Author(s):  
Magda Sofia Pacio-Quiterio ◽  
Jose Emilio G Rodriguez-Aguilar ◽  
Alvaro Montiel-Jarquin ◽  
Juan C. Lopez-Alvarenga ◽  
Sergio R. Sobrino-Cossio ◽  
...  
Keyword(s):  
Risk Factors ◽  
Primary Care ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Reflux Disease ◽  
Primary Care Patients
Sign in / Sign up

Export Citation Format

Share Document